[ad_1]
Verastem (NASDAQ:VSTM – Get Free Report) announced its quarterly earnings data on Thursday. The biopharmaceutical company reported ($0.39) earnings per share for the quarter, topping the consensus estimate of ($0.64) by $0.25. The firm had revenue of $2.14 million for the quarter, compared to analyst estimates of $6.01 million.
[ad_2]
Source link
Verastem (NASDAQ:VSTM) Releases Quarterly Earnings Results
